Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
antonio.chistolini@uniroma1.it
Antonio Chistolini
Ricercatore
Struttura:
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
E-mail:
antonio.chistolini@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Increased von Willebrand Factor Platelet-Binding Capacity Is Related to Poor Prognosis in COVID-19 Patients
THROMBOSIS AND HAEMOSTASIS
2023
Vaccine-induced immune thrombotic thrombocytopenia: a possible pathogenetic role of ChAdOx1 nCoV-19 vaccine encoded soluble SARS-CoV-2 spike protein
HAEMATOLOGICA
2022
Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants: comparison between patients with major congenital thrombophilia versus non-thrombophilic patients
INTERNAL AND EMERGENCY MEDICINE
2022
Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register
INTERNAL AND EMERGENCY MEDICINE
2022
Thromboembolic events following mRNA vaccines for COVID 19: a case series
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
2022
Immune thrombocytopenia during covid-19 pandemic: An italian monocentric experience
EJHAEM
2022
Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry
213S2 (2022) S11–S42
2022
Diagnostica di laboratorio e strumentale
Ematologia Smart, Edizioni Idelson Gnocchi 1908
2022
Complicanze in corso di emopatie ed emergenze emorragiche e trombotiche
Ematologia Smart, Edizioni Idelson Gnocchi 1908
2022
Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study
BIOMOLECULES
2022
SARS-CoV-2 infection predicts larger infarct volume in patients with acute ischemic stroke
FRONTIERS IN CARDIOVASCULAR MEDICINE
2022
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
2022
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients-30 months follow-up": Comment from Serrao et al
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
2022
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
2021
Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
2021
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
2021
Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia
NATURE COMMUNICATIONS
2021
Venous thromboembolism prophylaxis in plastic surgery: state of the art and our approach
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
2021
Single centre experience on Acquired Haemophilia A patients: Diagnosis, clinical management and analysis of factors predictive of response and outcome
HAEMOPHILIA
2021
Clinical course, management, and platelet activity assessment of splanchnic VITT: A case report
THROMBOSIS RESEARCH
2021
1
2
3
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma